XML 37 R26.htm IDEA: XBRL DOCUMENT v3.21.2
Equity (Tables)
9 Months Ended
Sep. 30, 2021
Equity [Abstract]  
Schedule of restricted stock unit activity
      
       Weighted
       Average
       Grant Date
    Shares  Fair Value
Non-vested, December 31, 2020   100,000   $1.34 
Granted   631,402   $5.31 
Canceled   (91,667)  $5.40 
Vested   (475,568)  $5.25 
Non-vested, September 30, 2021   164,167   $5.40 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
     
   September 30, 2021
Dividend yield   0.00%
Expected life   3.01 Years 
Expected volatility   84.01%
Risk-free interest rate   0.37%
Exercise price   $2.94 - $10.11 
Summary of Stock Options
                    
   Shares  Weighted Average Exercise Price  Weighted Average Remaining Contractual Term  Aggregate Intrinsic Value
Outstanding at December 31, 2020   2,255,267   $1.46    5.31 years    $10,247,548 
Granted   849,500    6.12    3.01 years    1,050 
Exercised   (487,876)   0.23        1,356,398 
Expired/Forfeited   (237,934)   5.66        28,854 
Outstanding at September 30, 2021   2,378,957   $2.95    4.46 years   $3,074,130 
Exercisable at period end   1,340,832   $1.68    4.34 years   $2,649,122